Inventor · disambiguated record
David L. Vander Jagt
Also filed as: VANDER JAGT DAVID L
9 granted patents·9 pending applications·56 citations·filing 1985–2019
87Inventor score
Top patents by PatentIndex Score
18 records- 0187US8841326B2Therapeutic curcumin derivativesVANDER JAGT DAVID L·Filed 2006·Granted Sep 23, 2014·13 cites·13 claims
- 0281US4806568AGossypol derivativesRESEARCH CORP·Filed 1985·Granted Feb 21, 1989·18 cites·10 claims
- 0379US8980954B2Substituted cis- and trans-stilbenes as therapeutic agentsVANDER JAGT DAVID L·Filed 2007·Granted Mar 17, 2015·2 cites·16 claims
- 0475US9187397B2Therapeutic curcumin derivativesSTC UNM·Filed 2014·Granted Nov 17, 2015·1 cites·19 claims
- 0555US6124498AHydroxynaphthoic acids and derivativesUNIV NEW MEXICO·Filed 1998·Granted Sep 26, 2000·6 cites·26 claims
- 0654US6034255AInhibitors of cholesterol esteraseUNIV NEW MEXICO·Filed 1999·Granted Mar 7, 2000·4 cites·7 claims
- 0754US5942631AInhibitors of cholesterol esteraseUNIV NEW MEXICO·Filed 1998·Granted Aug 24, 1999·9 cites·9 claims
- 0853US2022023172A1Cosmetic compositions and methods of useTRUJILLO KRISTINA·Filed 2019·Application pending·0 cites
- 0953US2016039734A1Therapeutic curcumin derivativesSTC UNM·Filed 2015·Application pending·0 cites
- 1049US9925153B2Therapeutic agents for skin diseases and conditionsSTC UNM·Filed 2014·Granted Mar 27, 2018·0 cites·16 claims
- 1149US2019160021A1Substituted Stilbenes as Inhibitors of NF-kappaB and Activators of Nrf2STC UNM·Filed 2018·Application pending·0 cites
- 1248US2014271470A1Targeted theranostics for metastatic prostate cancerSILLERUD LAUREL O·Filed 2014·Application pending·0 cites
- 1347US2005228038A111-Beta hydroxysteroid dehydrogenase type 1 inhibitors as anti-obesity/anti-diabetes compounds and 17-beta hydrosteroid dehydrogenase type I inhibitors as useful agents for the treatment of cancers, especially breast cancerVANDER JAGT DAVID L·Filed 2005·Application pending·0 cites
- 1445US2013178536A1Substituted cis- and trans-stilbenes as therapeutic agentsSTC UNM·Filed 2013·Application pending·0 cites
- 1543US2006252823A1Isocoumarin-based inhibitors of urokinase-type plasminogen activatorDECK LORRAINE M·Filed 2006·Application pending·0 cites
- 1641US6114545AInhibitors of cholesterol esteraseUNIV NEW MEXICO·Filed 1999·Granted Sep 5, 2000·3 cites·7 claims
- 1741US2006258752A1Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitorsVANDER JAGT DAVID L·Filed 2005·Application pending·0 cites
- 1837US2006276536A1Cancer treatment using curcumin derivativesVANDER JAGT DAVID L·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David L. Vander Jagt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →